Alpha 1-antitrypsin deficiency (patient information)

Revision as of 18:38, 18 December 2017 by Mazia Fatima (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Alpha 1-antitrypsin deficiency

Overview

What are the symptoms?

What are the causes?

When to seek urgent medical care?

Diagnosis

Treatment options

Where to find medical care for Alpha 1-antitrypsin deficiency?

What to expect (Outlook/Prognosis)?

Possible complications

Alpha 1-antitrypsin deficiency On the Web

Ongoing Trials at Clinical Trials.gov

Images of Alpha 1-antitrypsin deficiency

Videos on Alpha 1-antitrypsin deficiency

FDA on Alpha 1-antitrypsin deficiency

CDC on Alpha 1-antitrypsin deficiency

Alpha 1-antitrypsin deficiency in the news

Blogs on Alpha 1-antitrypsin deficiency

Directions to Hospitals Treating Alpha 1-antitrypsin deficiency

Risk calculators and risk factors for Alpha 1-antitrypsin deficiency

For the WikiDoc page for this topic, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Alpha-1 antitrypsin (AAT) deficiency is a condition in which the body does not make enough of a protein that protects the lungs and liver from damage. The condition can lead to emphysema and liver disease.

What are the symptoms of Alpha 1-antitrypsin deficiency?

  • Shortness of breath with and without exertion, and other symptoms of chronic obstructive pulmonary disease (COPD)
  • Symptoms of severe liver disease ( cirrhosis)
  • Unintentional weight loss
  • Wheezing

What causes Alpha 1-antitrypsin deficiency?

Alpha-1 antitrypsin (AAT) is a type of protein called a "protease inhibitor." It is made in the liver and it works to protect the lungs and liver.

AAT deficiency means there is not enough of this protein in the body. It is caused by a genetic defect. The condition is most common among Europeans and North Americans of European descent.

Studies show that AAT deficiency may be more common than was once thought.

Adults with severe deficiency will develop emphysema, often before age 40. Smoking can increase the risk of emphysema. Other patients can have higher levels of AAT in their blood, and therefore have a less severe condition.

Persons with this deficiency may also develop liver disease.

When to seek urgent medical care?

Call your health care provider if you develop symptoms of AAT deficiency.

Diagnosis

A physical examination may reveal a barrel-shaped chest, wheezing, or decreased breath sounds. The following tests may also help with diagnosis:

  • Alpha-1 antitrypsin blood test
  • Arterial blood gases
  • Chest x-ray
  • CT scan of the chest
  • Genetic testing
  • Lung function test

Your doctor may suspect you of having this condition if you develop:

  • Emphysema before age 45
  • Emphysema but have never smoked or been exposed to toxins
  • Emphysema and you have a family history of the condition
  • Liver disease or hepatitis and no other cause can be found
  • Liver disease or hepatitis and you have a family history of liver disease

Treatment options

Treatment for AAT deficiency involves replacing the missing AAT protein. The protein is given through a vein each week. However, it is not yet known who may benefit from such therapy.

Quitting smoking is crucial.

Other treatments for emphysema and cirrhosis are also used.

Where to find medical care for Alpha 1-antitrypsin deficiency?

Directions to Hospitals Treating Alpha 1-antitrypsin deficiency

What to expect (Outlook/Prognosis)?

Some people with this deficiency will not develop liver or lung disease. However, emphysema and cirrhosis can be life threatening.

Possible complications

  • Bronchiectasis
  • Cirrhosis or liver failure
  • Emphysema
  • Liver cancer

Sources

http://www.nlm.nih.gov/medlineplus/ency/article/000120.htm Template:WS Template:WH